Guidance on the use of inhaler systems (devices) in children under the age of 5 years with chronic asthma
National Institute for Clinical Excellence
Record ID 32000001773
English
Authors' objectives:
To provide guidance on the use of inhaler systems (devices) in children under the age of 5 years with chronic asthma.
Authors' recommendations:
Guidance
1.1 For children under the age of 5 years with chronic stable asthma both corticosteroids and bronchodilator therapy should be routinely delivered by pressurised metered dose inhaler (pMDI) and spacer system, with a facemask where necessary.
1.2 Where this combination is not clinically effective for the child and depending on the child's condition, nebulised therapy may be considered. In the case of children aged 3 to 5 years, a dry powder inhaler (DPI) may also be considered.
1.3 Choice of device to be made within the pMDI and spacer range should be primarily governed by specific individual need and the likelihood of good compliance. Once these factors have been taken into account, choice should be made on the basis of cost minimisation.
Authors' methods:
Systematic review
Details
Project Status:
Completed
URL for project:
http://www.nice.org.uk/article.asp?a=9832
Year Published:
2000
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Child
- Infant
- Nebulizers and Vaporizers
- Asthma
Contact
Organisation Name:
National Institute for Clinical Excellence
Contact Address:
MidCity Place, 71 High Holborn, London WC1V 6NA, UK. Tel: +44 020 7067 5800; Fax: +44 020 7067 5801
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Clinical Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.